T1	Participants 328 511	Sixty-eight women premedicated with midazolam were randomly allocated to coinduction with intravenous clonidine (group C) or placebo (group P) in this prospective, double-blind study.
T2	Participants 752 866	The primary endpoints studied were the number of PONV-free patients and patient satisfaction with respect to PONV.
